According to previous studies, SEZ6L2 has been indicated can be regulated by STAT3, which may elevate the expression of the vascular endothelial growth factor, promoting tumor angiogenesis and cancer progression [35, 36]. This evidence concerns the gene STAT3 and neoplasm.